Crea il mio profilo
Accesso pubblico
Visualizza tutto215 articoli
12 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
george haskoColumbia UniversityEmail verificata su cumc.columbia.edu
Partha Mukhopadhyay, MS, Ph.D.National Institutes of HealthEmail verificata su mail.nih.gov
Sandor Batkai MD, PhDCardior Pharmaceutical GmbHEmail verificata su cardior.de
Csaba SzaboProfessor, Chair of Pharmacology, University of Fribourg, SwitzerlandEmail verificata su unifr.ch
Jon MableyUniversity of BrightonEmail verificata su brighton.ac.uk
George KunosScientific Director, NIAAA/NIHEmail verificata su nih.gov
Rajesh MohanrajAssistant Professor, Department of Pharmacology and Therapeutics, UAE universityEmail verificata su uaeu.ac.ae
Zoltan Ungvari, M.D., Ph.D.Vascular Cognitive Impairment & Neurodegeneration Program OUHSCEmail verificata su ouhsc.edu
Bin GaoChief, Laboratory of Liver Diseases, NIAAA, NIHEmail verificata su mail.nih.gov
Balazs CsokaCelgeneEmail verificata su celgene.com
Németh ZoltánEmail verificata su ladypower.hu
Zoltan VargaSemmelweis University, HCEMMEmail verificata su med.semmelweis-univ.hu
Francisco Garcia SorianoProfessor Associado, Departamento de Clínica Médica da Faculdade de Medicina da Universidade de SãoEmail verificata su usp.br
Katalin Erdelyipost doctoral fellowEmail verificata su mail.nih.gov
Laszlo ViragProfessor of Medical Chemistry, University of Debrecen, Faculty of Medicine, HungaryEmail verificata su med.unideb.hu
Luca AntonioliDept Clinical and Experimental Medicine University of PisaEmail verificata su medmcs.unipi.it
Janos PalocziLSU Health Science CenterEmail verificata su lsuhsc.edu
E. Sylvester Vizi MD, PhD, MHAS, Ho...Hun-Ren Inst. of Experimental Medicine, and Semmelweis University, Department of Pharmacology andEmail verificata su koki.hu
Ken MackieProfessor Psychological and Brain Sciences, Indiana UniversityEmail verificata su indiana.edu
Douglas Osei-HyiamanNational Institutes of HealthEmail verificata su mail.nih.gov